Panbela to present at upcoming investor conferences

Minneapolis, sept. 07, 2021 (globe newswire) -- panbela therapeutics, inc. (nasdaq: pbla), a clinical stage biopharmaceutical company developing disruptive therapeutics for the treatment of patients with cancer today announced that it will present at upcoming investor conferences:

PBLA Ratings Summary

PBLA Quant Ranking